Poseida Therapeutics, Inc. (PSTX) Tops Q2 EPS by 21c
Tweet
Share
E-mailGet Alerts PSTX Hot Sheet
Price: $9.50 --0%
Financial Fact:
Income tax (benefit) provision: -253
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Income tax (benefit) provision: -253
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Poseida Therapeutics, Inc. (NASDAQ: PSTX) reported Q2 EPS of ($0.32), $0.21 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $20.01 million versus the consensus estimate of $11.96 million.
For earnings history and earnings-related data on Poseida Therapeutics, Inc. (PSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy
- Wall Street scrambles to lift Micron price targets ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
